₹41-₹43.00 Issue Size
₹11.61 Cr.
₹2,46,000.00 Max Bid
₹5,00,000.00
2700000 Min Qty
6000
BSE
About GOLDLINE PHARMACEUTICAL LIMITED
Goldline Pharmaceutical IPO is a book build issue of Rs11.61 crores. The issue is entirely a fresh issue of 0.27 crore shares of Rs 11.61 crore.
Goldline Pharmaceutical IPO opens for subscription on May 12, 2026 and closes on May 14, 2026. The allotment for the Goldline Pharmaceutical IPO is expected to be finalized on May 15, 2026. Goldline Pharmaceutical IPO will list on the BSE SME with a tentative listing date fixed as May 19, 2026.
Goldline Pharmaceutical IPO is set issue price band at Rs 41 to Rs 43 per share. The lot size for an application is 3,000 shares. The minimum amount of investment required by an individual investor (retail) is Rs 2,58,000 (6,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (9,000 shares), amounting to Rs 3,87,000.
GOLDLINE PHARMACEUTICAL LIMITED Timeline
| Issue open date | 12 May 2026 10 AM |
| Issue close date | 14 May 2026 5 PM |
| Allotment finalization | 15 May 2026 |
| Refund initiation | 18 May 2026 |
| Share credit | 18 May 2026 |
| Listing date | 19 May 2026 |